# Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients

> **NCT03617445** · PHASE2 · TERMINATED · sponsor: **University of Wisconsin, Madison** · enrollment: 3 (actual)

## Conditions studied

- Clostridium Difficile Infection Recurrence

## Interventions

- **DRUG:** FMT oral capsule
- **DRUG:** Oral Vancomycin
- **DRUG:** FMT oral placebo
- **DRUG:** Oral Vancomycin placebo

## Key facts

- **NCT ID:** NCT03617445
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-03
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study drug not available due to COVID-19 FDA restrictions
- **Last updated:** 2025-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03617445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03617445, "Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03617445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*